Tissue-engineered cellulose tubes for microvascular and lymphatic reconstruction: A translational and feasibility study.

Journal of plastic, reconstructive & aesthetic surgery : JPRAS 2024 Vol.97() p. 200-211

Will PA, Taqatqeh F, Fricke F, Berner JE, Lindenblatt N, Kneser U, Hirche C

관련 도메인

Abstract

[BACKGROUND] Lymphedema microsurgery is an emerging treatment modality, with dissimilar long-term outcomes. One of the main technical challenges in lymphatic microsurgery is the identification and availability of suitable donor vessels for anastomosis. Tissue engineering using biomaterials has demonstrated promise in addressing vessel quality issues in other fields, but its application in microsurgery is still limited.

[METHODS] Decellularized cellulose tubes were developed and bioengineered by decellularizing stems of Taraxacum-Ruderalia. The microscopic structure, mechanical properties, and residual DNA content of the cellulose tubes were evaluated. Human and murine skin fibroblasts and dermal lymphatic endothelial cells were isolated and cultured for recellularization studies. Biocompatibility, proliferative capacity, and ex-vivo endothelialization of the cellulose tubes were assessed as potential interposition grafts. Finally, the engineered cellulose tubes were assessed as interposing xenografts for lymphovenous anastomoses (LVA) in an ex-vivo swine limb model.

[RESULTS] The decellularized cellulose tubes exhibited a suitable microscopic structure, mechanical properties, and low residual DNA content. The tubes showed adequate biocompatibility, supported cell proliferation, and facilitated spontaneous ex-vivo endothelialization of lymphatic endothelial cells. In the swine limb model, LVA using the engineered cellulose tubes was successfully performed.

[CONCLUSION] This translational study presents the use of decellularized cellulose tubes as an adjunct for micro and supermicrosurgical reconstruction. The developed tubes demonstrated favorable structural, mechanical, and biocompatible properties, making them a potential candidate for improving long-term outcomes in lymphedema surgical treatment. The next translational step would be trialing the obtained tubes in a microsurgical in-vivo model.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 microsurgery 미세수술 dict 3
시술 microvascular 미세수술 dict 1
해부 lymphatic scispacy 1
해부 Tissue scispacy 1
해부 DNA scispacy 1
해부 dermal lymphatic endothelial cells scispacy 1
해부 grafts scispacy 1
해부 cell scispacy 1
해부 lymphatic endothelial cells scispacy 1
합병증 lymphovenous anastomoses scispacy 1
합병증 lymphedema scispacy 1
약물 cellulose scispacy 1
약물 [BACKGROUND] Lymphedema microsurgery scispacy 1
질환 xenografts scispacy 1
질환 Lymphedema C0024236
Lymphedema
scispacy 1
기타 donor vessels scispacy 1
기타 vessel scispacy 1
기타 Human scispacy 1
기타 murine skin fibroblasts scispacy 1
기타 swine limb scispacy 1

MeSH Terms

Animals; Tissue Engineering; Swine; Cellulose; Feasibility Studies; Anastomosis, Surgical; Lymphatic Vessels; Lymphedema; Microsurgery; Humans; Mice; Endothelial Cells; Tissue Scaffolds

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문